Colleen Sjogren - 27 Feb 2026 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Reporting relationship: Chief Commercial Officer
Issuer ticker: NUVB
Reported as of: 27 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Mar 2026, 20:01:48 UTC
Prior SEC filing: 18 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Stephen Dang, Attorney-in-Fact

Key filing fact

Colleen Sjogren filed Form 4 for Nuvation Bio Inc. (NUVB) on 03 Mar 2026.

Key facts

This page summarizes Colleen Sjogren's Form 4 filing for Nuvation Bio Inc. (NUVB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 20:01.

Change

Previous filing in this sequence was filed on 18 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002017751 Primary reporting owner

Sjogren Colleen

Relationship: Chief Commercial Officer
Address: C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK
Signature: /s/ Stephen Dang, Attorney-in-Fact
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUVB holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 84,000
Date: 27 Feb 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUVB transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +748,130
Change %
Price: $0.000000
Shares after: 748,130
Date: 27 Feb 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 748,130
Exercise price: $5.91
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Includes 3,000 shares acquired on November 19, 2025 under the 2021 Employee Stock Purchase Plan.

Footnote F2

Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.